Trijardy XR Drug Interactions: What to Avoid and What to Tell Your Doctor

Because Trijardy XR contains three different active ingredients, it has an extensive drug interaction profile. There are nearly 600 documented drug interactions, including 27 classified as major. Most interactions are manageable with awareness and monitoring — but some require avoiding certain drug combinations entirely. This guide covers the most clinically important interactions.

Always Tell Your Doctor About All Medications You Take

Before starting Trijardy XR, provide your prescriber with a complete list of all medications — including prescription drugs, over-the-counter medications, vitamins, supplements, and herbal products. Drug interactions are not limited to other prescriptions; some supplements and OTC products can interfere with how Trijardy XR works or increase side effect risk.

Major Interactions: Avoid or Use Alternative

These interactions are serious enough that the combination should typically be avoided or a therapeutic alternative should be used:

• ACE inhibitors (e.g., benazepril, captopril, lisinopril): Linagliptin increases the toxicity of ACE inhibitors, specifically elevating the risk of angioedema (severe swelling of the face, throat, or tongue). This is a potentially life-threatening combination. If you must take both, watch for facial swelling, throat tightness, or difficulty swallowing — seek emergency care immediately.
• Strong CYP3A4 inducers (e.g., apalutamide, rifampin, carbamazepine, phenytoin): These drugs significantly reduce linagliptin blood levels by speeding up its breakdown, potentially rendering it ineffective for blood sugar control. Use a therapeutic alternative when possible.
• Iodinated contrast media: Hold Trijardy XR at the time of (or before) any CT scan or procedure requiring IV contrast dye if your eGFR is below 60, you have liver disease, heart failure, or alcoholism. Restart only after confirming stable kidney function 48 hours post-procedure.

Moderate Interactions: Use With Caution and Monitor

These interactions require monitoring and possible dose adjustment, but don't necessarily require stopping one of the medications:

• Insulin or sulfonylureas (glipizide, glimepiride, glyburide): Trijardy XR can enhance the blood sugar-lowering effect of insulin and sulfonylureas, increasing hypoglycemia risk. Your doctor will typically reduce the insulin or sulfonylurea dose when adding Trijardy XR.
• Diuretics (furosemide, hydrochlorothiazide, chlorthalidone): Empagliflozin has a mild diuretic effect. Combined with other diuretics, this can cause excessive volume depletion, dehydration, and low blood pressure. Monitor for dizziness, lightheadedness, and kidney function changes.
• Cimetidine (Tagamet): This OTC heartburn medication can increase metformin blood levels by reducing its kidney clearance. If you use cimetidine regularly, your doctor should monitor for metformin toxicity signs.
• Moderate CYP3A4 inhibitors (e.g., fluconazole, diltiazem, verapamil): May increase linagliptin blood levels. Generally well-tolerated, but monitor for side effects.
• P-glycoprotein (P-gp) inhibitors/inducers: Linagliptin is a P-gp substrate; drugs that affect P-gp transport (like rifampin or some chemotherapy agents) can alter its blood levels and effectiveness.

Food and Lifestyle Interactions

• Alcohol: Increases the risk of lactic acidosis (from metformin) and ketoacidosis (from empagliflozin). Avoid or limit alcohol significantly while taking Trijardy XR.
• High-carbohydrate meals: Not a drug interaction, but important context — taking Trijardy XR without food increases GI side effects from metformin. Always take with a meal.
• Fasting (before procedures or illness): Metformin should be withheld during periods of restricted food/fluid intake (e.g., before surgery) due to increased lactic acidosis risk. Always alert your surgical or procedure team that you take Trijardy XR.

Disease Interactions to Know About

Beyond other drugs, certain medical conditions affect how Trijardy XR should be used:

• Chronic kidney disease (CKD): Not recommended if eGFR < 45; contraindicated if eGFR < 30. Kidney function should be checked before starting and periodically during treatment.
• Liver disease: Metformin use in hepatic impairment increases lactic acidosis risk. Not recommended for patients with significant liver disease.
• Heart failure: Monitor closely in patients with existing heart failure — empagliflozin may be beneficial, but volume depletion from the diuretic effect requires careful management of other cardiac medications.

For a full review of Trijardy XR side effects, see Trijardy XR Side Effects: What to Expect. Once your prescription is set, use medfinder to find a pharmacy near you that has it in stock.